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I. Introduction 
York County, the second most populated County in Maine with an estimated population 
of 204,191 (US Census 2017), has been greatly affected by the Opioid crisis. Opioids are 
prescription medications used to treat or relieve pains. They act by binding to specific receptors 
in the brain, spinal cord and gastrointestinal tract to reduce pain and can have other effects such 
as altering moods, decreased breathing and cause euphoria (SAMHSA, 2015). Synthetic opioids 
(other than methadone) are currently the main driver of drug overdose deaths (CDC, 2018) 
nationally and in Maine. The opioid crisis began in the 1990’s when physicians over prescribed 
opioids for pain relief without knowledge of the additive effect. The consequence of this over 
prescription coupled with the proliferation of illicitly manufactured drugs has led to a rise in 
Opioid Use Disorder (OUD) (HHS fact sheet, 2019).  
 Currently, York Public Health District has the third highest drug/medication overdose 
responses and the highest drug related arrests and violent crimes when compared to other public 
health districts in Maine (Maine SEOW, 2018). Consequently, the number of opioid related 
deaths in York County has increased over the years with 79 deaths occurring between 2007-2011 
and 166 deaths occurring between 2012-2016 (NORC, 2017). Also,  opioid mortality rate is 
estimated at 28.4 per 100,000 people which is higher than the estimated 22.5 per 100,000 people 
in Maine and 14.1 per 100,000 people in the US (NORC, 2017).  
Medicated Assisted Treatment (MAT) combines the use of medications with counselling 
and behavioral therapy, is an effective evidence-based treatment for OUD. The medications work 
by blocking the euphoric effects of opioids and relieving physiological cravings to normalize the 
brain and body functions (SAMHSA, 2015).  
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There are three FDA approved drugs used to treat OUD, these include: methadone (opioid 
agonist), Naltrexone (non-addictive opioid antagonist) and Buprenorphine (opioid 
agonist/antagonist). These drugs are highly regulated and require providers to obtain training and 
waivers to prescribe them. Methadone can only be prescribed in methadone clinics by waivered 
providers working in clinics approved to be opioid treatment programs, buprenorphine is 
prescribed by providers who get DEA waivers while Naltrexone, can be prescribed by any 
licensed health provider. Similarly, another important medication is Naloxone an FDA approved 
drug which is mainly used during an overdose emergency to reverse the effects of opioids 
(SAMHSA, 2015) and are also prescribed by providers to high risk OUD patient. 
Description of Problem 
As of 2018, York County remains designated as a Health Professional Shortage Area and 
a Medically Underserved Area/Population with 0.32 providers per 1,000 population (HRSA Fact 
Sheet-FY 2018 York, Maine). This inadequate provider  workforce makes accessing treatment 
for OUD difficult in York County. In addition, there are only 26 providers (including 4 Nurse 
Practitioners) certified to provide buprenorphine treatment (SAMHSA, 2019). This does not 
meet the demands for OUD treatment especially with evidence that shows that most waivered 
providers are prescribing to less patients  allowed by regulation (Andrilla, et al 2019). 
To address provider shortage and limited treatment infrastructure in York County, 
Southern Maine Health Care (SMHC) partnered with Nasson Health Care, Maine Behavioral 
Healthcare (MBH), Frannie Peabody Center (FPC), North East Mobile Health Services 
(NEMHS) and the Kennebunk Police Department (KPD) to obtain funding from HRSA to 
support a comprehensive strategic planning process designed to improve the current model of 
care available for treatment of OUD. The goal of the project is to strengthen the current 
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infrastructure in rural communities in York County to ensure the provision of comprehensive 
prevention, treatment and recovery services to reduce opioid related morbidity and mortality.  
II. Literature Review 
The Drug Addiction Treatment Act of 2000 (DATA 2000), permits qualified physicians 
to obtain a waiver from the separate registration requirements of the Narcotic Addict Treatment 
Act – 1974 to treat opioid dependency with Schedule III, IV, and V medications or combinations 
of such medications that have been approved by FDA for that indication. To obtain waivers, 
physicians must complete 8 hours of required training (24 hours for nurse practitioners and 
physician assistants) to become qualified to prescribe to a maximum of 30 patients with OUD. 
The limit can be increased to 100 and then to 275 after at least one year of initial approval 
(SAMHSA). The DEA list shows that since 2012, the MAT workforce has increased nationwide 
because of the inclusion of nurse practitioners and physician assistants with 45.9% and 24.5% of 
urban counties having a waivered NP or PA respectively and 13.8% and 4.6% of rural counties 
having a waivered NP or PA respectively. Despite the increase in waivered providers, MAT 
remains largely under-utilized with many waivered providers not offering MAT services or 
limiting the size of their MAT patient panel (Andrilla et al, 2019). The proportion of heroin 
admissions with treatment plans that included receiving medication-assisted opioid therapy fell 
from 35% in 2002 to 28% in 2010 (SAMHSA’s Treatment Episode Data Set (TEDS) 2002-2010) 
highlighting the under prescription of MAT. Among providers, there are many barriers to 
implementing MAT for OUD in their clinical practice including: inadequate training, lack of 
institutional and clinical peer support, poor care coordination, complex insurance requirements, 
low reimbursements, burdensome regulatory process and providers stigma (Storholm et al 2017, 
Jones et al 2019 and Haffajee et al 2018).  
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Treatment/ Encounters of OUD by Provider Type 
Emergency Department (ED) Providers: 
The ED sees a high volume of individuals experiencing opioid related overdoses and 
Opioid Withdrawal (OW) cases. From July 2016 through September 2017, a total of 142,557 ED 
visits suspected to be opioid-involved overdoses (15.7 per 10,000 visits) were reported across 45 
states of the US, with Maine reportedly having a significant quarterly rate increases from third 
quarter 2016 to third quarter 2017 (Vivolo-Kantor et al, 2018). In the ED, Buprenorphine 
administration can be done by any licensed provider without further certification. The ED plays 
an important role in the initiation and sustenance of MAT when OUD is identified in patients 
since ED physicians are obligated to intervene by initiating Buprenorphine treatment (Cisewski 
et al, 2018). There is evidence that ED-initiated Buprenorphine treatment is associated with 
increased engagement in outpatient treatment programs and reduced illicit drug use (D'Onofrio et 
al 2017). However, some views of Buprenorphine as a substitution for another drug is a common 
barrier in its utilization in the ED (Cisewski et al, 2018) and is underutilized in EDs (Larochelle 
et al, 2017). Cisewski et al, 2018 suggest that providing patient from the ED with outpatient 
multimodal medication-assisted treatment (MAT) clinic information for planned follow up 
within 48-72H is a critical component of such ED encounters. 
Primary Care Providers: 
Primary care settings are an important entry point for patient suffering from various 
chronic disease including OUD and with the wealth of medical and behavioral information 
available for diagnosis, it is the ideal place to integrate MAT if adequate organizational support 
is in place to support providers (Mannelli and Wu, 2016). The number of primary care providers 
with DEA waivers to prescribe MAT has increased across the US, especially with the inclusion 
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of NP and PA to provide office-based MAT such as Naltrexone and Buprenorphine yet, many of 
these providers report not using them (Andrilla, Moore, Patterson and Larson, 2019). There are 
notable barriers to effectively integrating MAT treatment into primary care setting. For example, 
rural providers have noted the lack of mental health or psychosocial support as a barrier to 
incorporating MAT into their practices (Andrilla, Coulthard and Patterson, 2018). Other barriers 
waivered providers reported include lack of belief in agonist treatment, lack of time to see more 
patients, and low reimbursement rates while non-waivered physicians cite diversion of 
medication and managing numerous patients as reasons for not being waivered to treat OUD 
(Huhn and Dunn, 2017). Studies have shown that to effectively implement OUD treatment and 
increase MAT access in primary care, multidisciplinary and coordinated care delivery models are 
essential (Lagisetty et al 2017). 
EMS Providers: 
As first responders, EMS providers see a high volume of drug overdose cases. Naloxone an 
opioid antagonist that works to reverse the effect of the opioids are administered promptly during 
such encounters. From 2012–2016, the rate of Emergency Medical Services (EMS) naloxone 
administration events increased 75.1%, from 573.6 to 1004.4 administrations per 100,000 EMS 
events (Cash et al, 2018). However, low administration of Naloxone has been reported in some 
areas resulting from the difficulty in recognizing patient and scene characteristics in an overdose 
event by EMS providers (Sumner et al, 2016). EMS providers are often the first line of contact 
with individuals at particularly high risk for opioid related morbidity and mortality making them 
uniquely situated to create critical linkages to treatment and supports for individuals with OUD. 
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III. Research Design 
A review of literature provided background information that clarifies the roles of 
providers and barriers they face in prescribing MAT for OUD. Although the primary care setting 
serves as good place to implement OUD management, patients who are misusing opioids 
sometime require emergency care from the emergency department or from first responders such 
as EMS providers. The aim of this study is to identify the challenges these different provider 
types encounter in the management of patients with OUD and the service/treatment gaps in York 
County.  
This capstone used data collected as part of the Rural York County Opioid Planning Project 
to address the following research questions: 
1. What treatment gaps exist in York County? 
2. What are the challenges/barriers providers working in different clinical setting face in 
treating OUD patients?  
Location of Study 
The location of the study is in York County which has the third highest rate of overdose 
deaths in Maine. Data was gathered through providers focus groups which was conducted in five 
different locations and an online survey sent to EMS providers working in York County. 
Study Population  
Participants in this study included medical providers currently working in organizations 
located in York County Maine. The York consortium representatives identified providers within 
their organization to participate in the focus groups and online survey.  
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Recruitment email that provided information about the purpose of the study was sent to 
each participant. For the online survey, the recruitment email contained a link that led to the 
survey.  
Protection of Human Subjects 
A request for determination of research involving human subjects was sent to the office 
of Research Integrity and Outreach at USM with background information about this study and 
subsequently an IRB approval was obtained. In addition, before conducting each survey, 
participants were informed about the purpose of the study and that participating was voluntary 
after which an informed consent was obtained.  Those participating in the focus group were 
additionally informed that their responses will be recorded. Those who proceeded with the focus 
group or online survey were believed to have given an informed consent. Both survey responses 
were deidentified by removing all identifying properties in the reports generated from analysis of 
the data 
Data Collection: 
This study used both qualitative and quantitative data collected as part of the Rural York 
County Opioid Planning Project funded by HRSA. Data collection occurred from January 2019 
to March of 2019. Data collection was done through regional providers’ focus groups, online 
survey administered and using publicly available data sources.  
1. Secondary Data: Existing data, including publicly available data from SAMHSA, CDC 
and US Census Bureau was used to examine prevalence of OUD, provider capacity as 
well as treatment and recovery services in York County. 
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2. Providers Focus Group: Six regional focus groups with providers in York County was 
conducted with providers in Biddeford, Kennebunk, Sanford, Springvale, Sacopee Valley 
and Waterboro. Each lasted approximately 45 minutes and elicited responses from 
providers on key topics of interest such as: managing OUD patients; barriers and 
facilitators to implementing comprehensive prevention and treatment programs for OUD; 
and gaps in services of OUD management (See Appendix 2 for focus group guide). 
3. EMS Online Survey: This was administered online using the Snap Survey Tool. This 
survey examined key domains including: opioid knowledge and attitudes, stigma, training 
needs, barriers to managing the opioid crisis, and initiative fatigue among first responders. 
It included open-ended response questions with a 5-point Likert- type scale ranging from 
(1) “strongly agree” to (5) “strongly disagree” as end points and a middle score (3) “neither 
agree nor disagree.” Low scores denoted positive conformity to a question whereas a high 
score was associated with negative conformity (See Appendix 3 for EMS survey). 
Data Analysis 
Both quantitative and qualitative data were analyzed accordingly. 
Quantitative Data Analysis: Data from the Snap survey tool was exported into SPSS software. 
Descriptive statistics was then used to analyze the frequency and percentage to determine the 
demographic distribution and response to each question. 
 Qualitative Data Analysis: Qualitative data from transcripts of providers’ focus groups and 
open-ended responses from EMS surveys was systematically coded to derive high level themes. 
Emerging themes and constructs that relate to this study such as barriers and treatment gaps was 
compiled.  
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Target Audience: 
The key audience is the Rural York County Planning Consortium members (i.e. 
representatives from Southern Maine Health Care (SMHC), Nasson Health Care, Maine 
Behavioral Healthcare (MBH), Frannie Peabody Center (FPC), North East Mobile Health 
Services (NEMHS) and the Kennebunk Police Department, (KPD). This capstone will inform 
their current work on expanding access to MAT and increasing efficiency, integration and 
coordination among and between service providers. Also, the results of the findings will be 
relevant to a broader public health and health systems audience who are trying to address the 
current Opioid crisis. 
Limitation of Study Design: 
The methods and data analytic strategies used to examine provider perspectives varied 
between first responders and providers working in healthcare centers. While the qualitative data 
from the focus group generated responses from providers based on open ended semi-structured 
interview questions, the online survey of EMS providers contained largely Likert scale responses 
with some opportunities for more in-depth responses through open-ended questions. While this is 
a limitation of the study, both data collection strategies focused on gathering data on similar 
domains and this was the most feasible way to get data from busy EMS providers. Also, all data 
was self-reported and collected from individuals who agreed to participate in the study. This 
means that their responses may not be generalizable to the broader group of first responders and 
providers in York County. 
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IV. Results 
The data analysis resulted in identification of one primary theme reflecting the gaps in 
treatment: essential treatment availability and four themes reflecting the challenges to managing 
OUD in York County: access to care, inadequate workforce, stigma and patients engagement. 
Also, demographic information describing the survey participants was included. 
Demographics 
PCP: Focus group was conducted in four different primary care setting with 35 providers 
participating in them. The setting included 2 primary care clinics, 1 walk-in clinic and 1 
behavioral health clinic in York County Maine. Among the participants, only 6 were waivered to 
prescribe MAT with only 3 prescribing to patients. 
ED Providers: One focus group was conducted for ED providers and had a total of 5 participants 
including physicians (3) and Physician Assistant (2). None of the providers acknowledged they 
are waivered to prescribe MAT to patients. 
EMS Providers: Fifteen EMS providers completed the online survey. Majority of the 
respondents were male (80%), have been employed for over 20 years (33%) and have EMS 
license level of Paramedics (53%).  
See table 1 below.  
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Table 1: Demographic information of providers 
Demographics EMS Provider PCP ED Provider 
# of participants  15 respondents 35 participants 5 participants 
Gender M = 80%  
F = 20% 
Not recorded Not recorded 
License type Paramedics= 53% 
Advanced EMT=27% 
EMT Basic=20% 
Physicians= 28% 
NP=20% 
BH=31% 
PA=5% 
RN=3% 
Admin Staff = 11% 
ED Physicians = 60% 
PA= 40% 
# waivered Trained to administer 
Naloxone 
6 waivered with only 3 
prescribing 
None 
 
Findings 
1. Treatment Gaps: Essential Treatment Availability  
Overall responses from all providers’ type show that most essential treatment services are 
lacking in York County. Respondents identified four subthemes which includes: lack of 
knowledge of how to access resources, detox centers, inadequate treatment services in primary 
care settings and service shortage as gaps in treatment. 
Lack of Knowledge of Resources  
While 40% of EMS providers reported they were aware of treatment resources, both PCP and 
ED providers were uncertain about resources for their patients as a provider shared: “The biggest 
issue for me is just knowing how to access the correct resources.” In addition to this, all provider 
types mentioned that patients are not adequately followed up due to the lack collaboration among 
providers in the community.  
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A provider noted in a statement that: “I thought about this a couple years ago but within our 
community we didn't have adequate follow-up. I didn't have any resources within my community 
to connect people with treatment beyond MAT. At least a couple of years ago and until now, I 
didn't feel my patients would have the therapy that they needed. There was no point in me 
prescribing Suboxone to somebody if they were not going to be followed up in a responsible way, 
I felt. Then I just haven’t done it since then. I don't feel there is a really big need for me to do 
that right now. I don't know how much it would benefit my patients to put that extra time in.” 
Most providers noted that since they are unaware of treatment resources and do not get feedback 
for patients they refer for mental health care, it affects their clinical decision when managing 
OUD patients. 
 
Inadequate Treatment Services in Primary Care   
PCP providers noted that in most primary care settings, OUD treatment services are either not 
offered or are inadequate as described by a provider: “ The fact that we don’t offer it in primary 
care, that’s a gap. Or it’s not readily available in primary care as it could be. I haven’t seen 
enough patients to know.” This inadequacy in the primary setting can also be attributed to the 
limited number of waivered prescribers in York County.  
 
Service Shortage 
Similar responses among all provider type mentioned service shortage as a current gap within the 
service systems that is not yet addressed. Services such as mental and behavioral health services, 
detox centers and pharmacies to fill prescriptions were among notable services lacking in York 
County.  
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The closest detox center to York County is far away in Portland and is not easily accessible for 
patients. One provider noted: “The biggest gap is the only one that does it is Milestone in 
Portland and almost none of my patients can get a ride there.” In addition to this the PCPs noted 
the importance of having community wrap around services that is needed as a preventive service 
for pain management.  
 
2. Challenges: Access to Care: 
Majority of EMS providers (66%) reported that there were few barriers for people trying to 
access treatment for OUD unlike the PCP and ED Providers who believed York County has 
barriers that affect patients’ access to treatment. The high-level sub-themes derived from their 
responses include: transportation and financial barrier (prescription cost and insurance coverage). 
 
Transportation: 
Transportation is needed for patients to travel to treatment site, unfortunately in York County 
there are no adequate transportation system and most patient do not have cars making it difficult 
for them to get to the clinic. This was a problem echoed by both PCP and ED provider as a major 
barrier. A provider summarized a patient’s complaint: “My friend had a car today, so this is how 
I got here.” There’s so many barriers out here, like you said, just how rural we are. How do you 
get there? Pay for the gas to get there?” Providers noted that they are time crunched and will prefer 
patients arriving on time for their appointments. The lack of transportation and distance of treatment 
centers discourages providers from referring or managing such patients.  
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Financial Barrier: 
Both PCP and ED providers reported that the high cost of medication and lack of insurance 
coverage was a major challenge for patients to access treatment. A statement that summarized 
this by a provider was thus: “Yeah, anyone can come here regardless of insurance or not, but 
they can't always pay for the medication.” And provider another noted: “Seeing a counselor, 
provider to prescribe, then the cost of medication itself is expensive. That is a big one” Providers 
also noted that they are unaware of the cost or insurance coverage for OUD treatment and cannot 
provide such information to patients. Inability of patients to pay for these medications influences 
their adherence to treatment.  
 
3. Challenges: Stigma 
All provider types acknowledged that stigma is associated with drug use and can affect how care 
is rendered in different care setting and how people are treated in the community. For example, 
patients living in Halfway houses can lose their housing because taking MAT is not considered 
soberness. A provider reported this about a patient who was at the verge of losing housing: “One 
thing that recently came up for me was I have a patient living in a halfway house and they 
wouldn’t allow him to take Suboxone while he was living in a halfway house. Between myself 
and his social worker we were able to convince the person running the halfway house that if he 
didn't do this he was going to use. The person running the halfway house felt that wasn’t a good 
alternative.” Also, stigma among providers who believe that the patients are intentionally 
harming themselves was summarized thus: “there are still pockets of stigma of they're doing this 
to themselves and why do we keep resuscitating them when they come in in respiratory cardiac 
arrest. There is still some of that out there and it’s a constant push to try to overcome it.” 
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Overall, providers believed that education about OUD can help to eliminate stigma in healthcare 
settings and the community. 
 
4. Challenges: Inadequate Workforce Capacity 
Most providers mentioned that their workforce capacity was not enough in providing necessary 
treatment for OUD. Two subthemes cited were: staff shortage and training needs. 
 
Staff Shortage 
Although EMS providers noted they were adequately staffed, they reported being fatigued from 
the large volume of overdose related calls. Meanwhile, both PCP and ED providers mentioned 
that given the amount of time needed to see patients coupled with the limited number of 
dedicated staffs such as case managers, nurses, and recovery coaches it was difficult to manage 
OUD. A provider summarized this by saying: “In most places some people wear many 
hats…and there is just little time to focus on treating MAT patients.” The providers went further 
highlighting the importance of having dedicated staff  who can help patients to find resources for 
treatment and follow up with them to ensure they are getting the care they need. 
 
Training Needs 
While majority of EMS providers (87%) reported that they are adequately trained to identify and 
manage overdose symptoms, majority of PCP and ED providers mentioned they need more 
training on how to manage OUD, how to get waivered and information about referral resources 
in the community. 
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An EMS provider stated: “we need very little training, we have been bombarded by this…we 
know how to manage overdose patients. We need more resources.” In addition, the PCP and ED 
providers who mentioned they need more training noted that they will prefer training that are not 
time consuming and is customized to fit their busy schedules. The long training hours required 
for getting waivered was a deterrent for those who are not waivered. 
 
5. Challenges: Patient Engagement in Treatments 
Patient’s resistance or denial of OUD condition was a notable response from all provider types. 
Among the EMS providers, they noted that people do not call 911 during an emergency and most 
times refuse administration of Narcan. As an EMS provider noted “…the challenge when Narcan 
is given and the patient then has the right to sign off even though in my opinion they are not 
competent as the drug is still in their system, but according to MEMS and the on line medical 
control physicians, they have that right as they technically are alert and oriented at that time 
although there is always the potential that the Narcan will wear off (due to the short half-life” 
Similarly, PCP noted that most OUD patients deny their conditions, and some do not keep to 
their appointments which they believed might be due to the time of the day for their appointment 
conflicting with their work or child care. Furthermore, an ED provider gave this summary of the 
difficulty in keeping patients engaged: “It takes a commitment. That’s huge. It’s just very hard to 
keep them engaged in the treatment.” According to the providers, patients need support from 
their community and families in order to continue treatment. Most patients who do not have 
these sometimes relapse. Although this is beyond the providers intervention, they believe that 
eliminating environmental triggers such as street drugs will be helpful for engaging patients. 
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V. Discussion 
The recent rise in opioid related deaths in many rural areas compared to urban areas has 
become a major public health concern (Mack et al, 2017). This is the case in rural York County 
where increase in overdose deaths has been reported in the past years. Also, given that it is 
designated as a health care provider shortage area calls for quick intervention. This study 
revealed the gaps in treatment resources and challenges providers working in different clinical 
setting in York County face in managing OUD. Among the responses gathered from all provider 
types, it is apparent that lack of essential treatment resources, access to care, stigma, inadequate 
workforce capacity and patient engagement in treatment are major barriers to managing OUD. 
 Similar responses among all providers that highlight major concerns that must be 
addressed in order to improve OUD treatment in York County include: stigma, inadequate 
workforce capacity, patients’ engagement and limited treatment resources. Like York County, 
most rural areas do not have adequate workforce, mental and behavioral services (RHIhub, 2019) 
and detox centers that are close by (Lenardson, et al 2009). Also, stigma was a notable barrier 
across all provider types. Stigma emanates from the language used for addiction, set policies, 
treatment setting (Wakeman &Rich, 2018), belief that addiction is a willful choice, and the 
separation of OUD treatment from the rest of the medical system (Olsen, et al 2014). However, 
providers believed that this can be overcome by educating providers and community members 
about the causes of OUD. Furthermore, engaging patients in treatment was a major barrier 
identified across all provider types. Patient refusal to be treated either during an overdose 
emergency or in an office setting was attributed to state laws and no shows. This is a major 
concern in addressing the high rate of overdose deaths occurring in the entire state. 
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 Also, there was notable difference in the training needs reported by providers. While 
majority of EMS providers reported they have enough training and knowledge of OUD resources 
within the community, most PCP and ED providers had major concerns about their lack of 
knowledge of both prescription cost and treatment resources within the community. This was a 
major finding of this study as it highlights an immediate need to inform providers about OUD 
resources that are located around their practice area. Another significant difference in providers 
response was their answers to the barriers people face in accessing treatment. While more than 
half of EMS providers reported that there were few barriers to accessing treatment, both PCP and 
ED providers overwhelmingly noted that inadequate transportation and financial constraints 
contributed to their inability to manage patients with OUD. 
Overall responses among the ED providers reveal that they are interested in engaging OUD 
patients’ in treatments but will require more information about OUD resources within the 
community and how to get waivered. This is different from a study that identified ED Providers’ 
perception of buprenorphine as a substitution to another drug as a barrier to prescribing in ED 
setting (Cisewski et al, 2018). Also, while this study revealed that EMS Providers in York 
County are adequately trained to identify and manage an overdose situation, a different study 
revealed that EMS Providers inability to identify an overdose, was a major barrier to managing 
overdose patients (Sumner et al, 2016). However, the barriers identified by the PCP in this study 
such as inadequate staffing, training needs, stigma (Storholm et al 2017, Jones et al 2019 and 
Haffajee et al 2018) lack of mental health services (Andrilla, Coulthard and Patterson, 2018), and 
time constraints from seeing patients (Huhn & Dunn, 2017) were similar finding in other primary 
care setting.  
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VI. Recommendations 
Based on responses from providers, the following suggestion will help alleviate the identified 
provider level challenges in York County: 
• Trainings: tailored trainings that fits into providers busy schedule is recommended. These 
training can be delivered in different format including online or in person training. 
• Staffing: Recruitment and retention of dedicated staff such as case managers and 
recovery coaches and training of existing staff on OUD management can help bridge the 
staffing shortage. Also, these staff can work with providers and patients to provide 
relevant information about accessible treatments. 
• Stigma: Educating providers, staff and community members about OUD causes and 
dangers of stigma for patients 
• Improve collaboration : Most providers noted inadequate follow up and lack of 
knowledge of OUD resources as a barrier. This can be improved by increasing 
collaboration across different organizations. 
• Increase access to OUD treatment: Incentivizing more providers to get waivered and 
prescribe MAT is a crucial solution for York County. Having more waivered prescribers 
and behavioral/mental providers would also reduce the travel time for patients to access 
treatment within the community. 
• Monitoring: Tracking the progress of established OUD programs such as the HUB and 
Spoke model to ensure continuous performance improvement is crucial. Also, 
maintaining proper implementation of the prescription monitoring program to ensure 
adherence to evidence-based prescription practice in the ED and Primary care settings. 
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VII. Conclusion 
This study identified several factors that needs to be addressed in order to decrease the high 
rate of overdose deaths in York County. As different strategies to curb down the prevalence of 
overdose deaths emerge, this study can inform the ongoing efforts of increasing efficiency and 
collaboration among providers and expanding MAT for OUD treatment. Also, it highlights the 
need to improve treatment resources, staff recruitment and provider training particularly ED and 
PCP. As well, all providers will benefit by learning how to eliminate stigma that arise during 
encounter with patients. 
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Appendix 1 
Capstone Integration with Muskie School of Public Service MPH Program 
MPH Competency Relevant Course Work Capstone Application 
• Critically evaluate 
epidemiological studies 
and literature 
• Identify organizational 
and community concerns, 
assets and deficit.  
• Apply evidence-based 
principles and knowledge 
to decision making 
• Use data to inform public 
health decision making 
MPH 650 Applied Public 
Health Research and 
Evaluation 
• Literature reviews 
• Focus group and 
survey 
• In making 
recommendations 
• Data analysis 
 
• Describe determinants of 
health, incorporate 
evidence and tools to 
inform public health 
practice 
 
MPH 565 Social and 
Behavioral Health 
  
• Literature reviews 
and 
recommendations 
• Secondary data 
analysis 
• Statistical analysis and 
interpretation of results  
MPH 435/535 Introduction 
to Epidemiological 
Research and MPH 545 
Applied Biostatistical 
Analysis 
• Study design 
• Data analysis 
• Interpretation of 
survey and focus 
group results 
• Develop work plan and 
timeline 
MPH 630 Health Planning 
and Marketing  
Preparation od workplan 
and time line 
• Demonstrate written and 
oral skills with diverse 
audience 
Capstone Capstone draft and 
presentation 
 
 
 
Challenges in OUD Management       Anumaka, 2019
   
 
27 
 
Appendix 2 
Provider Focus Group Questionnaire 
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Provider Focus Group Questionnaire  
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Appendix 3 
EMS Online Survey Questionnaire   
• I am confident in how to recognize an apparent drug overdose as it differs from 
other medical emergencies, such as a diabetic coma. 
• I am going to need more training before I would feel confident to help someone who 
had overdosed. 
• There are few barriers for people trying to access treatment for opioid use disorder. 
• In my work, I am aware of community resources for people struggling with opioid 
use disorder. 
• What barriers existing for EMS staff in responding to and managing individuals 
with opioid use disorder? 
• What resources do EMS staff and organizations need to effectively address opioid 
use disorder in your community? 
• What types of education and training on opioid use disorder are needed for EMS 
staff? 
 
 
 
 
 
 
 
